Abstract
In the dynamic field of cancer research, the hunt for breakthroughs in early disease detection is critical for improving patient outcomes. Exosomes are garnering attention for their potential in cancer diagnostics. The emergence of exosomes and their cargo as important biomarkers in disease monitoring, early discovery, and precision medicine may herald a transformative era in patient care.